Navigation Links
Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and Reduces Exacerbations
Date:8/27/2009

ZURICH, Aug. 27 /PRNewswire/ -- Nycomed and Forest Laboratories today announced that results of four phase III trials have been published in the prestigious peer-reviewed medical journal The Lancet showing that roflumilast, a phosphodiesterase 4 (PDE4) inhibitor, improved lung function and reduced exacerbations in patients with moderate to severe COPD.

COPD is an under-diagnosed progressive lung disease that may lead to death. Worldwide, COPD kills four people every minute and the World Health Organization (WHO) predicts that it will be the third leading cause of death by 2030. WHO estimates that 80 million people have moderate to severe COPD.

Roflumilast, a once-a-day oral tablet, would be the first in an entirely new class of treatment for COPD if it receives regulatory approval from the authorities in Europe (EMEA) and the US (FDA). The phase III placebo-controlled trials of roflumilast evaluated the treatment in two 12-month (Lancet 2009; 374: 685-694) and two six-month studies (Lancet 2009; 374: 695-703), involving 4,500 patients in ten countries. Details of the results of the four studies will be published in The Lancet on August 29 (data and information under embargo until Friday, August 28 at 00:01am GMT).

The two 12-month studies published in The Lancet demonstrated that roflumilast produced a statistically significant and clinically relevant reduction in exacerbations (lung attacks that need treatment with systemic steroids or lead to hospitalisation), even for patients who were also taking long-acting bronchodilators. The studies showed a reduction in moderate to severe exacerbations by 17 percent per patient per year (rate of 1.14 events per year with roflumilast vs. 1.37 per year with placebo, p<0.001). The reduction in exacerbations was irrespective of concomitant treatment with long-acting
'/>"/>

SOURCE Nycomed
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Adamas Pharmaceuticals Signs CRADA With U.S. Navy to Conduct Preclinical Studies of Triple-Combination Antiviral Drug Therapy for Influenza A, Including the Novel H1N1 Pandemic Strain
2. Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss
3. BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
4. PARI LC Plus and PRONEB Ultra Used in Two Perforomist Studies on Improving COPD Therapies
5. Infant Formula Company Teams With the University of Virginia Pediatrics Department to Conduct Clinical Studies
6. Covance Announces Integrated Radiolabeled Clinical Pharmacology Studies
7. School of Dentistry Studies Link Between Oral Health and Memory
8. Cancer Treatment Centers of America(R) Studies Treatment That Aims Chemotherapy Directly at Ovarian Cancer Cells
9. New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring
10. Merz Pharmaceuticals Announce Three Studies of NT-201 - (Botulinum neurotoxin type A Free From Complexing Proteins)
11. Two New Clinical Studies Show That Limited Exposure to Blood Transfusion Significantly Increases Morbidity and Mortality After Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Puerto Rico , May 17, 2013  Serving a ... Puerto Rico , Caribbean Imaging and Radiation Therapy ... its radiation therapy capabilities with the acquisition of an Elekta ... . Versa HD offers clinicians the versatility to deliver ... the body, while also enabling treatment of highly complex cancers ...
(Date:5/17/2013)...  PENTAX Medical, a healthcare industry leader in ... in ultrasound imaging, recently announced renewed collaborative efforts ... innovation in the development of Endoscopic Ultrasound Systems ... PENTAX Medical endoscopic portfolio have formed one of ... This agreement will continue to grow their long-standing ...
(Date:5/17/2013)... Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ( http://www.oramed.com ... today that the United States Food and Drug Administration ... for ORMD-0801, its oral insulin capsule. "We ... proceed," stated Nadav Kidron , CEO ... for Oramed and we look forward to continuing to ...
Breaking Medicine Technology:Puerto Rico's Caribbean Imaging and Radiation Therapy Center Orders Elekta's New Versa HD System for Treatment of Cancer Patients 2PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 2PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 3Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3
... Kingdom , May 20 Today, in a world ... treatment drugs on a permanent ,not for profit, basis potentially saving ... killer of women in the UK and as part of Asda,s ... Iressa, used to treat lung cancer, is now available for ...
... ATLANTA, Georgia , May 20, 2010 , ... - Critical Care Pharmacology ... , , ... solutions to more than 1,300 healthcare organizations,has partnered with the American Association of ...
Cached Medicine Technology:In a World First, Asda Announces 'Not for Profit' Price on All Cancer Treatment Drugs 2In a World First, Asda Announces 'Not for Profit' Price on All Cancer Treatment Drugs 3Elsevier/MC Strategies Partners with American Association of Critical-Care Nurses to Launch Interactive, Online Pharmacology Course 2Elsevier/MC Strategies Partners with American Association of Critical-Care Nurses to Launch Interactive, Online Pharmacology Course 3Elsevier/MC Strategies Partners with American Association of Critical-Care Nurses to Launch Interactive, Online Pharmacology Course 4Elsevier/MC Strategies Partners with American Association of Critical-Care Nurses to Launch Interactive, Online Pharmacology Course 5Elsevier/MC Strategies Partners with American Association of Critical-Care Nurses to Launch Interactive, Online Pharmacology Course 6Elsevier/MC Strategies Partners with American Association of Critical-Care Nurses to Launch Interactive, Online Pharmacology Course 7
(Date:5/19/2013)... The Fat Loss Code program developed by ... that help people get in shape, and gain a healthy ... program also is a natural fat loss system that provides ... of this fat loss diet program claimed that The Fat ... people keep body fat off long-term. After Shawn Stevenson launched ...
(Date:5/19/2013)... Agora Health Limited developed by Rachael Linkie is a ... to increase memory power naturally and effectively. The program ... re-new their entire health from the inside out. It also ... fatigued mind. In addition, the program helps people keep their ... author claimed that this program can help people overcome a ...
(Date:5/19/2013)... 2013 Beginning Wednesday, May 29 and running ... (RRVBC) will feature “Hot Dog Wednesdays" and Ice Cold Slushies ... provide hot dogs and all the fixin's to donors on ... throughout the summer. “Donors are our lifeline. The summer months ... adequate blood supply. This is a small way for ...
(Date:5/19/2013)... Vedra Beach, Florida (PRWEB) May 19, 2013 ... value and market access, is pleased to unveil a ... trade show environment that provides a powerful array of ... to partners in the US and abroad. , HE-Xpo ... and will offer attendees the look and feel of ...
(Date:5/19/2013)... 2013 The Da Vinci robot lawyers ... in the nation’s first trial involving a Da Vinci ... State Superior Court, was filed by the widow of ... complications in a robot-assisted prostate removal, according to a ... robotic surgery lawsuit alleges those complication’s hastened his ...
Breaking Medicine News(10 mins):Health News:Weight Loss Secrets | How “The Fat Loss Code” Helps People Gain A Healthy Life And Get In Shape - Health Review 2Health News:How To Increase Memory Power | How “Agora Health Limited” Helps People Improve Their Memory Naturally And Effectively – Health Review 2Health News:Hot Dog Wednesdays and Ice Cold Slushies Return to Rock River Valley Blood Center for the Summer 2Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 2Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 3Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 3Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 4
... use of aspirin, acetaminophen, or other pain relievers for ... dysfunction among healthy men. ,As analgesic use is ... of renal dysfunction could have a significant impact on ... suggested that regular use of popular pain killers such ...
... The Indian pharmaceutical companies hope to strike a pot ... triggered a price war that is likely to escalate ... cases has lured many companies to develop anti-AIDS drugs ... innovative approaches to pricing. ,The anti-AIDS drug market, ...
... has been a therapeutic challenge to most of the ... resistance of the bacteria causing them to the available ... highly effective in treating patients with pneumococcal bacteraemia associated ... the field of anti microbials as pneumococcal resistance is ...
... to miscarrry after IVF treatment- but losing even a few ... are urging overweight women to change their diets, and take ... have long been known to have problems conceiving naturally, and ... do not match those of those with a normal body ...
... easy combat for any practising physician, is now being ... (IL-4R), which acts as an IL-4 antagonist, appears to ... lung function and in preventing asthma symptoms. ,In ... of Virginia Health Sciences Center in Charlottesville, and colleagues ...
... is undoubtedly the most common neurological disorder and one of ... die of stroke each year and more than 15 million ... is about the recovery - whether the patient would recover ... the National Institute of Neurological Disorders and Stroke (NINDS) in ...
Cached Medicine News:
Maddox Rod, short handle (12cm)...
... Snellen chart remains to most popular ... of different optotypes can be displayed ... landolt Cs, tumbling Es and kaye ... can be shown and a range ...
Snellen 20' Eye Test Chart....
Ultrasonic Pachymeter UP-1000 is fast, accurate corneal thickness measurements....
Medicine Products: